GILEAD SCIENCES, INC. — Director's Dealing 2018

Oct 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-10-07

Reporting Person: Hamill Laura (EVP, Worldwide Commercial Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-07	Non-qualified Stock Option (Right to Buy)	$76.24	A	87680	Acquired	2028-10-07	Common Stock (87680)	Direct
2018-10-07	Restricted Stock Unit	$	A	32795	Acquired		Common Stock (32795)	Direct

Footnotes

F1: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.